The ectopic expression of NF-κB disturbs oncogenic miR-221 and miR-222 expression in prostate carcinoma and glioblastoma cell lines, possibly by NF-κB binding to two sites in the upstream of miR-221/222 promoter (77). Here, NFKB1 is linked to glioblastoma.